Celldex Therapeutics Stock Options Expiring on 21st of February

CLDX Stock  USD 19.95  0.06  0.30%   

Celldex Therapeutics Market Cap Over Time

   Market Cap   
       Timeline  

Celldex Total Stockholder Equity

Total Stockholder Equity

784.36 Million

At this time, Celldex Therapeutics' Total Stockholder Equity is fairly stable compared to the past year.

Celldex Therapeutics Corporate Management

Ronald PepinChief Bus. Officer and Sr. VPProfile
Patrick TillSenior CommunicationsProfile
Prof SchlessingerCoFounder BoardProfile
Diane MDSenior OfficerProfile
Margo MDSenior AffairsProfile

Additional Tools for Celldex Stock Analysis

When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.